Wholomics

Curated by Signal

Provider of liquid biopsy test for early cancer detection

Overview

Provider of liquid biopsy test for early cancer detection. It offers AI-based non-invasive and screening method to detect the presence of cancer-specific molecular signatures in the blood, allowing early detection of a multitude of cancer types.

Key facts

Founded: 2022
Headquarters: Ried Im Innkreis, Austria
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Dawn Bio
Developer of treatments for womens reproductive health
Life Sciences TechnologyWien, Austria
CNSystems Medizintechnik
Equipment for non-invasive, continuous monitoring of blood pressure for healthcare providers
Life Sciences TechnologyGraz, Austria
cortEXplore
Developer of neuronavigation system for brain surgeries
Life Sciences TechnologyLinz, Austria

About Wholomics

What does Wholomics do?

Provider of liquid biopsy test for early cancer detection.

Where is Wholomics headquartered?

Wholomics is headquartered in Ried Im Innkreis, Austria.

When was Wholomics founded?

Wholomics was founded in 2022.

Which sector is Wholomics in?

Wholomics operates in Life Sciences Technology.

Who are Wholomics's competitors?

Companies similar to Wholomics include Dawn Bio, CNSystems Medizintechnik, and cortEXplore.